Chlorinated lipids and fatty acids: An emerging role in pathology

Pharmacology and Therapeutics

Volumn 115, Issue 3, 2007, Pages 400-409

  Spickett, Corinne M ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Chlorohexadecanal; Chlorohydrin; Inflammation; Myeloperoxidase

Indexed keywords

2 CHLOROHEXADECANAL; ALDEHYDE DERIVATIVE; CELL ADHESION MOLECULE; CHLORINE DERIVATIVE; CHLOROHYDRIN DERIVATIVE; FATTY ACID; HALOGEN; HYPOCHLOROUS ACID; LIPID; LIPOPROTEIN; MYELOPEROXIDASE; NITRIC OXIDE; PHOSPHOLIPID; PROSTAGLANDIN DERIVATIVE; PUNAGLANDIN DERIVATIVE; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CHLORINATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; HALOGENATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIPID ANALYSIS; LIPID PEROXIDATION; MAMMAL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SYNTHESIS; UPREGULATION;

ANIMALS; CHLORINE COMPOUNDS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FATTY ACIDS; HUMANS; HYDROCARBONS, CHLORINATED; INFLAMMATION; LIPIDS; OXIDATIVE STRESS; PEROXIDASE;

EID: 34548461722     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.06.002     Document Type: Review

References (76)

1. Albert C.J., Crowley J.R., Hsu F.F., Thukkani A.K., and Ford D.A. Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal. J Biol Chem 276 (2001) 23733-23741
2. Arnhold J., Osipov A.N., Spalteholz H., Panasenko O.M., and Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 31 (2001) 1111-1119
3. Arnhold J., Osipov A.N., Spalteholz H., Panasenko O.M., and Schiller J. Formation of lysophospholipids from unsaturated phosphatidylcholines under the influence of hypochlorous acid. Biochim Biophys Acta 1572 (2002) 91-100
4. Arnhold J., Furtmuller P.G., and Obinger C. Redox properties of myeloperoxidase. Redox Rep 8 (2003) 179-186
5. Ashby M.T., Carlson A.C., and Scott M.J. Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids. J Am Chem Soc 126 (2004) 15976-15977
6. Baker B.J., and Scheuer P.J. The punaglandins: 10-chloroprostanoids from the octocoral Telesto riisei. J Nat Prod 57 (1994) 1346-1353
7. Bjorn H., Sundin P., Wesen C., Mu H., Martinsen K., Kvernheim A.L., et al. Chlorinated fatty acids in membrane lipids of fish. Naturwissenschaften 85 (1998) 229-232
8. Brennan M.L., and Hazen S.L. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 14 (2003) 353-359
9. Butler A. Mechanistic considerations of the vanadium haloperoxidases. Coord Chem Rev 187 (1999) 17-35
10. Carr A.C., van den Berg J.J., and Winterbourn C.C. Chlorination of cholesterol in cell membranes by hypochlorous acid. Arch Biochem Biophys 332 (1996) 63-69
11. Carr A.C., Vissers M.C., Domigan N.M., and Winterbourn C.C. Modification of red cell membrane lipids by hypochlorous acid and haemolysis by preformed lipid chlorohydrins. Redox Rep 3 (1997) 263-271
12. Carr A.C., Winterbourn C.C., Blunt J.W., Phillips A.J., and Abell A.D. Nuclear magnetic resonance characterization of 6 alpha-chloro-5 beta-cholestane-3 beta,5-diol formed from the reaction of hypochlorous acid with cholesterol. Lipids 32 (1997) 363-367
13. Carr A.C., van den Berg J.J., and Winterbourn C.C. Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipid: formation of haloamines and halohydrins. Biochim Biophys Acta 1392 (1998) 254-264
14. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94 (1994) 437-444
15. Dembitsky V.M., and Srebnik M. Natural halogenated fatty acids: their analogues and derivatives. Prog Lipid Res 41 (2002) 315-367
16. Dever G., Stewart L.J., Pitt A.R., and Spickett C.M. Phospholipid chlorohydrins cause ATP depletion and toxicity in human myeloid cells. FEBS Lett 540 (2003) 245-250
17. Dever G., Wainwright C.L., Kennedy S., and Spickett C.M. Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion. Acta Biochim Pol 53 (2006) 761-768
18. Duguet A., Iijima H., Eum S.Y., Hamid Q., and Eidelman D.H. Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice. Am J Respir Crit Care Med 164 (2001) 1119-1126
19. Erridge C., and Spickett C.M. Oxidised phospholipid regulation of Toll-like receptor signalling. Redox Rep 12 (2007) 76-80
20. Erridge C., Webb D.J., and Spickett C.M. 25-Hydroxycholesterol, 7beta-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res 41 (2007) 260-266
21. Folkes L.K., Candeias L.P., and Wardman P. Kinetics and mechanisms of hypochlorous acid reactions. Arch Biochem Biophys 323 (1995) 120-126
22. Gribble G.W. The diversity of naturally produced organohalogens. Chemosphere 52 (2003) 289-297
23. Hazell L.J., Davies M.J., and Stocker R. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem J 339 Pt 3 (1999) 489-495
24. Hazen S.L., Hsu F.F., Duffin K., and Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem 271 (1996) 23080-23088
25. Heinecke J.W., Li W., Mueller D.M., Bohrer A., and Turk J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 33 (1994) 10127-10136
26. Hoy A., Leininger-Muller B., Kutter D., Siest G., and Visvikis S. Growing significance of myeloperoxidase in non-infectious diseases. Clin Chem Lab Med 40 (2002) 2-8
27. Ikeda-Saito M., Shelley D.A., Lu L., Booth K.S., Caughey W.S., and Kimura S. Salicylhydroxamic acid inhibits myeloperoxidase activity. J Biol Chem 266 (1991) 3611-3616
28. Iwase H., Yamada Y., Uemura H., Nakaya H., Takatori T., Nagao M., et al. Effect of monochlorohydrins of linoleic acid on guinea-pig cardiac papillary muscles. Biochem Biophys Res Commun 231 (1997) 295-298
29. Jerlich A., Pitt A.R., Schaur R.J., and Spickett C.M. Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS. Free Radic Biol Med 28 (2000) 673-682
30. Jiang Q., Blount B.C., and Ames B.N. 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. J Biol Chem 278 (2003) 32834-32840
31. Kawai Y., Morinaga H., Kondo H., Miyoshi N., Nakamura Y., Uchida K., et al. Endogenous formation of novel halogenated 2′-deoxycytidine. Hypohalous acid-mediated DNA modification at the site of inflammation. J Biol Chem 279 (2004) 51241-51249
32. Kawai Y., Kiyokawa H., Kimura Y., Kato Y., Tsuchiya K., and Terao J. Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 45 (2006) 14201-14211
33. Kettle A.J., Gedye C.A., and Winterbourn C.C. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 321 Pt 2 (1997) 503-508
34. Klebanoff S.J. Myeloperoxidase. Proc Assoc Am Physicians 111 (1999) 383-389
35. Kutter D., Devaquet P., Vanderstocken G., Paulus J.M., Marchal V., and Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ?. Acta Haematol 104 (2000) 10-15
36. Malle E., Marsche G., Arnhold J., and Davies M.J. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta 1761 (2006) 392-415
37. Marquez L.A., and Dunford H.B. Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 269 (1994) 7950-7956
38. Marsche G., Heller R., Fauler G., Kovacevic A., Nuszkowski A., Graier W., et al. 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler Thromb Vasc Biol 24 (2004) 2302-2306
39. Messner M.C., Albert C.J., Hsu F.F., and Ford D.A. Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. Chem Phys Lipids 144 (2006) 34-44
40. Mohiuddin I., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 133 (2006) 143-149
41. Panasenko O.M., and Arnhold J. Linoleic acid hydroperoxide favours hypochlorite- and myeloperoxidase-induced lipid peroxidation. Free Radic Res 30 (1999) 479-487
42. Panasenko O.M., Arnhold J., Schiller J., Arnold K., and Sergienko V.I. Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorous acid. Biochim Biophys Acta 1215 (1994) 259-266
43. Panasenko O.M., Evgina S.A., Driomina E.S., Sharov V.S., Sergienko V.I., and Vladimirov Y.A. Hypochlorite induces lipid peroxidation in blood lipoproteins and phospholipid liposomes. Free Radic Biol Med 19 (1995) 133-140
44. Panasenko O.M., Spalteholz H., Schiller J., and Arnhold J. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic Biol Med 34 (2003) 553-562
45. Pattison D.I., and Davies M.J. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem 13 (2006) 3271-3290
46. Pattison D.I., Hawkins C.L., and Davies M.J. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol 16 (2003) 439-449
47. Podrez E.A., Abu-Soud H.M., and Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28 (2000) 1717-1725
48. Prutz W.A. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys 332 (1996) 110-120
49. Prutz W.A. Interactions of hypochlorous acid with pyrimidine nucleotides, and secondary reactions of chlorinated pyrimidines with GSH, NADH, and other substrates. Arch Biochem Biophys 349 (1998) 183-191
50. Rees M.D., Pattison D.I., and Davies M.J. Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation. Biochem J 391 (2005) 125-134
51. Ruf J., and Carayon P. Structural and functional aspects of thyroid peroxidase. Arch Biochem Biophys 445 (2006) 269-277
52. Senthilmohan R., and Kettle A.J. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch Biochem Biophys 445 (2006) 235-244
53. Shaw P.D., and Hager L.P. Biological chlorination. IV. Peroxidative nature of enzymatic chlorination. J Am Chem Soc 81 (1959) 6527-6528
54. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
55. Shishehbor M.H., Brennan M.L., Aviles R.J., Fu X., Penn M.S., Sprecher D.L., et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108 (2003) 426-431
56. Spalteholz H., Wenske K., Panasenko O.M., Schiller J., and Arnhold J. Evaluation of products upon the reaction of hypohalous acid with unsaturated phosphatidylcholines. Chem Phys Lipids 129 (2004) 85-96
57. Spickett C.M., Rennie N., Winter H., Zambonin L., Landi L., Jerlich A., et al. Detection of phospholipid oxidation in oxidatively stressed cells by reversed-phase HPLC coupled with positive-ionization electrospray [correction of electroscopy] MS. Biochem J 355 (2001) 449-457
58. Stelmaszynska T., Kukovetz E., Egger G., and Schaur R.J. Possible involvement of myeloperoxidase in lipid peroxidation. Int J Biochem 24 (1992) 121-128
59. Thukkani A.K., Hsu F.F., Crowley J.R., Wysolmerski R.B., Albert C.J., and Ford D.A. Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J Biol Chem 277 (2002) 3842-3849
60. Thukkani A.K., Albert C.J., Wildsmith K.R., Messner M.C., Martinson B.D., Hsu F.F., et al. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J Biol Chem 278 (2003) 36365-36372
61. Thukkani A.K., Mchowat J., Hsu F.F., Brennan M.L., Hazen S.L., and Ford D.A. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108 (2003) 3128-3133
62. Thukkani A.K., Martinson B.D., Albert C.J., Vogler G.A., and Ford D.A. Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury. Am J Physiol Heart Circ Physiol 288 (2005) H2955-H2964
63. van Dalen C.J., Whitehouse M.W., Winterbourn C.C., and Kettle A.J. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 327 Pt 2 (1997) 487-492
64. van der Vliet A., Eiserich J.P., Halliwell B., and Cross C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272 (1997) 7617-7625
65. van Pee K.H., and Patallo E.P. Flavin-dependent halogenases involved in secondary metabolism in bacteria. Appl Microbiol Biotechnol 70 (2006) 631-641
66. Verbitski S.M., Mullally J.E., Fitzpatrick F.A., and Ireland C.M. Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J Med Chem 47 (2004) 2062-2070
67. Vissers M.C., Carr A.C., and Chapman A.L. Comparison of human red cell lysis by hypochlorous and hypobromous acids: insights into the mechanism of lysis. Biochem J 330 Pt 1 (1998) 131-138
68. Vissers M.C., Carr A.C., and Winterbourn C.C. Fatty acid chlorohydrins and bromohydrins are cytotoxic to human endothelial cells. Redox Rep 6 (2001) 49-55
69. Wang J., and Slungaard A. Role of eosinophil peroxidase in host defense and disease pathology. Arch Biochem Biophys 445 (2006) 256-260
70. White R.H., and Hager L.P. Occurrence of fatty acid chlorohydrins in jellyfish lipids. Biochemistry 16 (1977) 4944-4948
71. Wildsmith K.R., Albert C.J., Anbukumar D.S., and Ford D.A. Metabolism of myeloperoxidase-derived 2-chlorohexadecanal. J Biol Chem 281 (2006) 16849-16860
72. Wildsmith K.R., Albert C.J., Hsu F.F., Kao J.L., and Ford D.A. Myeloperoxidase-derived 2-chlorohexadecanal forms Schiff bases with primary amines of ethanolamine glycerophospholipids and lysine. Chem Phys Lipids 139 (2006) 157-170
73. Winterbourn C.C., and Kettle A.J. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 29 (2000) 403-409
74. Winterbourn C.C., van den Berg J.J., Roitman E., and Kuypers F.A. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys 296 (1992) 547-555
75. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
76. Zhang R., Brennan M.L., Shen Z., Macpherson J.C., Schmitt D., Molenda C.E., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122